In this CE activity, experts in the field will assess how advances in imaging and new therapies for the management of geographic atrophy secondary to age-related macular degeneration can be ...

Geographic atrophy is a subtype of advanced age-related macular degeneration (AMD). It causes blind spots in the center of vision and a permanent loss of visual sharpness. AMD progresses through ...

Brown D. Pegcetacoplan for geographic atrophy in AMD. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago. Jaffe G. Avacincaptad for geographic atrophy in AMD.

today announced positive topline 3-month data from a clinical trial of its K8 implant in patients with geographic atrophy (GA), the most serious form of dry age-related macular degeneration (AMD).

MENOMONIE (WQOW) - The Menomonie Police Department is responding after claims by Eau Claire officials an officer dropped off a homeless person 'under the influence of drugs and suffering from ...

PST-611-CT1 is a first-in-human single ascending dose trial aiming to confirm the favorable safety profile of the drug and validate the maximal dose for the Phase II proof-of-concept study, in six to ...

in six to twelve dry age-related macular degeneration (AMD)/geographic atrophy (GA) patients. The study PST-611-CT1 is expected to start early Q2 2025 with a readout anticipated by the end of 2025 ...